Which Surgical AI Platforms Are Actually Worth the Cost?

Hospitals and device teams are being asked to buy AI platforms for the operating room.
Most vendors answer a question about cost with a request for a quote.
That leaves buyers comparing claims instead of prices.
A careful buyer can still judge value by checking what the public record supports.
To score the platforms yourself, use The Surgical AI Platform Buyer’s Guide.
Surgical AI platforms are three different products
One label covers three kinds of products with different buyers and different costs.
Build platforms are used by engineering teams that make surgical robots and imaging AI.
Hospital platforms capture and analyze operating room video and data for the people who run the OR.
Vendor ecosystems tie AI features to one manufacturer’s robot or devices.
Comparing a free framework with a hospital subscription produces a meaningless ranking.
Each type has to be judged against its own kind.
Open frameworks are cheap to license and expensive to use
NVIDIA describes Isaac for Healthcare as a platform for developing healthcare robots, with simulation, synthetic data and pre-trained models.
Its workflows cover robotic surgery, robotic ultrasound and telesurgery, and its code is published on GitHub.
Holoscan is NVIDIA’s platform for real-time processing of video and sensor data at the edge.
Medtronic says its Touch Surgery Aide platform incorporates Holoscan, which shows a large manufacturer building on it.
NVIDIA says Virtual Incision cut system latency by 3x on its MIRA robot using Holoscan software and hardware, a company claim that no independent test has confirmed.
Project MONAI is an open-source framework for medical imaging AI under the Apache 2.0 license.
None of these tools is the expensive part of a project.
The bill comes from GPUs, edge hardware, engineering time, and the regulatory work on the finished product.
NVIDIA offers a 90-day trial license of NVIDIA AI Enterprise for production use, but its page does not state the price afterward.
Hospital platforms rarely publish a price
Touch Surgery, Caresyntax ORI, Theator, and Proximie published no prices in the sources reviewed.
That makes the pricing unit the first thing to pin down.
A quote priced per room, per case, or per site produces very different totals for the same hospital.
The extras matter as much as the license.
Installation, EHR integration, storage and training can all sit outside the quoted price.
Read the claim, then read the record
Proximie says its users have seen operating room productivity rise by up to 24%.
The same release says customers gain an average of one additional surgical case per room per day.
“Up to” marks a best case, so the typical result and the measurement period are the numbers that matter.
Medtronic says the Touch Surgery ecosystem is in more than 1,500 operating rooms.
The FDA record shows what its first cleared AI function actually does.
The clearance letter dated June 4, 2026 covers a feature that shows a visual overlay when three listed Hugo instruments leave the camera view.
The record says the feature processes about 10 frames per second and does not control equipment.
That is a real clearance, and it is also a narrow one.
Oracle’s announcement of June 24, 2026 says Theator will deliver AI-generated operative reports into the Oracle Health record.
A study in the Journal of the American College of Surgeons found AI-generated reports more accurate than surgeon-written ones, 87.3% against 72.8%, across 158 robotic prostate cases at one center.
The study’s authors include Theator’s chief executive, so the result is peer-reviewed but not independent.
Ownership can change under a contract
Caresyntax described itself in a January 8, 2024 release as a vendor-neutral platform used in more than 3,000 operating rooms.
On November 14, 2026, Caresyntax web addresses forwarded to truspera.com.
That page states that Truspera has acquired the ORI, ORION, and RWE products and platform.
No announcement of the date, terms, or customer arrangements was found in the sources reviewed.
A buyer with a multiyear contract under the old brand would need to know who supports it.
Ownership, support, and data terms belong in the contract before the first invoice.
Where the money is best spent
On the public evidence, the open frameworks are the best value for engineering teams because the license cost is low.
Theator is worth a pilot for hospitals on Oracle Health with documentation gaps, tested on the hospital’s own procedures.
Touch Surgery’s cleared function is an early step for hospitals buying Hugo, not a full platform.
Proximie is worth evaluating for throughput if reference customers can show before and after scheduling data.
Caresyntax ORI deserves attention in mixed-vendor operating rooms only after ownership and support terms are confirmed in writing.
Five questions that expose the real cost
What is the pricing unit, and what is not in the quote?
Which claims have independent or peer-reviewed support, and who wrote the studies?
What is the regulatory status of each function being bought?
What happens to the contract, support, and data if the vendor is sold?
Is the hospital’s data used to train the vendor’s models or shared with partners?
The last question is live, because Proximie’s own release says it contributes real-world surgical data to NVIDIA’s model development.
The Surgical AI Platform Buyer’s Guide scores seven platforms on public evidence and adds a cost worksheet and 18 vendor questions.


